Title
In type 2 diabetes, SGLT2 inhibitors reduced risk for serious hyperkalemia without increasing hypokalemia
Date Issued
01 September 2022
Access level
metadata only access
Resource Type
journal
Author(s)
Rachmasari K.
Publisher(s)
American College of Physicians
Abstract
SOURCE CITATION: Neuen BL, Oshima M, Agarwal R, et al. Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials. Circulation. 2022;145:1460-70. 35394821.
Start page
JC104
Volume
175
Issue
9
Language
English
OCDE Knowledge area
Endocrinología, Metabolismo (incluyendo diabetes, hormonas)
Subjects
DOI
Scopus EID
2-s2.0-85138459365
PubMed ID
Source
Annals of internal medicine
ISSN of the container
00034819
Sources of information:
Directorio de Producción Científica
Scopus